| 000 | 01344 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514021918.0 | ||
| 264 | 0 | _c20020806 | |
| 008 | 200208s 0 0 eng d | ||
| 022 | _a0724-8741 | ||
| 024 | 7 |
_a10.1023/a:1013319408893 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, M L | |
| 245 | 0 | 0 |
_aBioavailability and bioequivalence: an FDA regulatory overview. _h[electronic resource] |
| 260 |
_bPharmaceutical research _cDec 2001 |
||
| 300 |
_a1645-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aDrugs, Generic |
| 650 | 0 | 4 | _aDrugs, Investigational |
| 650 | 0 | 4 | _aLegislation, Drug |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aShah, V | |
| 700 | 1 | _aPatnaik, R | |
| 700 | 1 | _aAdams, W | |
| 700 | 1 | _aHussain, A | |
| 700 | 1 | _aConner, D | |
| 700 | 1 | _aMehta, M | |
| 700 | 1 | _aMalinowski, H | |
| 700 | 1 | _aLazor, J | |
| 700 | 1 | _aHuang, S M | |
| 700 | 1 | _aHare, D | |
| 700 | 1 | _aLesko, L | |
| 700 | 1 | _aSporn, D | |
| 700 | 1 | _aWilliams, R | |
| 773 | 0 |
_tPharmaceutical research _gvol. 18 _gno. 12 _gp. 1645-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1013319408893 _zAvailable from publisher's website |
| 999 |
_c11697189 _d11697189 |
||